Orhan Kemal Yücel

Prognostic impact of the psoas muscle index, a parameter of sarcopenia, in patients with diffuse large B-cell lymphoma treated with rituximab-based chemoimmunotherapy

Utku İltar, Hasan Sözel, Yıldız Kılar Sözel et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 32 citations

Medicine, Immunology, Oncology +16

Azacitidine versus decitabine in patients with refractory anemia with excess blast—Results of multicenter study

Ozan Salim, Tayfur Toptaş, Esin Avşar et al. · Leukemia Research · 2016 · 16 citations

Medicine, Hematology, Pharmacology +6

Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning

Orhan Kemal Yücel, Rima M. Saliba, Gabriella Rondon et al. · Cancer · 2017 · 13 citations · Full text

Medicine, Geriatric Medicine, Hematology +17

Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

Mehmet Sinan Dal, Bahar Uncu Ulu, Ant Uzay et al. · Annals of Hematology · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacology +13

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden et al. · Turkish Journal of Hematology · 2021 · 11 citations · Full text

Medicine, Hematology, Infectious Diseases +13